Furthermore, in MS patients and EAE mice, there is a marked increase in the levels of IFN-γ and IL-17, signature cytokines for Th1 and Th17 cells, respectively (Arellano et al., 2017). The gene discussed is IL17A; the disease is myeloid sarcoma.